Xiong Wang, PhD, is a clinician-scientist and principal investigator at the Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China. His research focuses on cancer multi-omics, non-coding RNA biology, tumor immune microenvironment, molecular diagnostics, and interpretable bioinformatics tools, with the goal of translating large-scale cancer omics data into clinically meaningful biomarkers, diagnostic models, and therapeutic hypotheses; what differentiates his work is the integration of laboratory medicine, computational oncology, molecular diagnostics, and translational cancer research. He has published at least 17 oncology-related articles as first/co-first author or corresponding/co-corresponding author in peer-reviewed journals, including Frontiers in Oncology, Scientific Reports, Annals of Hematology, Annals of Surgical Oncology, Talanta, Bioinformatics, BMC Bioinformatics, Discover Oncology, and Journal of Analytical Atomic Spectrometry, with representative contributions covering circular RNAs in human cancer, colorectal cancer, ovarian cancer, glioma, pancreatic cancer, acute myeloid leukemia, breast cancer detection, prostate cancer methylation diagnostics, and the development of CancerOmicsStudio, a web server for integrative and interpretable multi-omics cancer analysis; according to Google Scholar, his publications have received more than 11,400 citations, with an H-index of 32 and an i10-index of 65. Beyond his own publications, he contributes to academic journals through peer review and scholarly service, supporting the evaluation, improvement, and dissemination of high-quality biomedical research. His long-term professional goal is to develop clinically interpretable cancer biomarkers and decision-support tools by combining tumor biology, non-coding RNA regulation, molecular pathology, artificial intelligence-assisted diagnostics, and multi-omics data integration, particularly in precision oncology and laboratory medicine. He has distinctive strengths in active listening, scientific communication, interdisciplinary collaboration, leadership, mentoring, project management, and problem-solving, which enable him to guide students and collaborators, coordinate multidisciplinary research projects, refine research questions, and translate complex biological and computational findings into practical clinical and laboratory medicine applications. His broader academic vision is to bridge discovery-oriented cancer biology and real-world clinical diagnostics, so that omics-based findings can be converted into robust, reproducible, and clinically useful tools for cancer detection, classification, prognosis, and therapeutic stratification.